Study of Tissue Samples From Patients With Glioma or Other Brain Tumors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by National Cancer Institute (NCI).
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00967200
First received: August 26, 2009
Last updated: April 20, 2010
Last verified: August 2009

August 26, 2009
April 20, 2010
November 2003
December 2008   (final data collection date for primary outcome measure)
Pathophysiology of gliomas and identification of molecular markers that may predict prognosis and progression or that could identify new therapeutic approaches [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00967200 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
Identification of Genes Involved in the Pathogenesis of Gliomas by Transcriptome Analysis

RATIONALE: Studying the genes expressed in samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.

PURPOSE: This research study is looking at tissue samples from patients with glioma or other brain tumors.

OBJECTIVES:

Primary

  • To better understand the pathophysiology of gliomas and identify molecular markers that may predict prognosis and progression or that could identify new therapeutic approaches.

Secondary

  • To compare gene expression profiles, in terms of response to treatment, and attempt to isolate subgroups of patients with objective response to certain types of chemotherapy or radiotherapy.

OUTLINE: This is a multicenter study.

Biological samples are collected from patients at time of surgery for diagnostic and/or treatment purposes.

Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
Brain and Central Nervous System Tumors
  • Other: laboratory biomarker analysis
  • Other: pharmacogenomic studies
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
150
Not Provided
December 2008   (final data collection date for primary outcome measure)

DISEASE CHARACTERISTICS:

  • Histologically confirmed glioma of any grade or rare primary brain tumor

    • Planning surgery to remove the tumor

PATIENT CHARACTERISTICS:

  • No urgent situation
  • No known or suspected active infection
  • Must not be deprived of liberty or protected by law
  • Not pregnant or nursing

PRIOR CONCURRENT THERAPY:

  • No concurrent participation in other trials that require a period of exclusion
Both
18 Years and older
No
Not Provided
France
 
NCT00967200
CDR0000626732, CHUM-DGS-2003/0402, CHUM-UF7745, INCA-RECF0467
Not Provided
Not Provided
University Hospital, Montpellier
Not Provided
Investigator: Luc Bauchet, MD University Hospital, Montpellier
National Cancer Institute (NCI)
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP